Valuation: TransMedics Group, Inc.

Market Cap 2.7B 2.34B 2.17B 2.01B 3.78B 257B 3.85B 25.74B 10.08B 128B 10.12B 9.9B 430B P/E 2026 *
43.3x
P/E 2027 * 25.1x
Enterprise Value 2.7B 2.34B 2.17B 2.01B 3.78B 257B 3.85B 25.74B 10.08B 128B 10.12B 9.9B 430B EV / Sales 2026 *
3.68x
EV / Sales 2027 * 3.03x
Free-Float
96.35%
Yield 2026 *
-
Yield 2027 * -
1 day-4.17%
1 week+4.64%
Current month+12.06%
1 month+12.06%
3 months-26.15%
6 months-44.44%
Current year-38.82%
1 week 68.8
Extreme 68.8
79.28
1 month 67.44
Extreme 67.44
79.28
Current year 60.1
Extreme 60.105
151.85
1 year 60.1
Extreme 60.105
156
3 years 36.42
Extreme 36.4201
177.37
5 years 10
Extreme 10
177.37
10 years 10
Extreme 10
177.37
Manager TitleAgeSince
Chief Executive Officer 57 1998-07-31
Director of Finance/CFO 55 2024-12-01
Chief Operating Officer 43 2023-02-01
Director TitleAgeSince
Director/Board Member 57 1998-07-31
Chairman 81 2010-12-31
Director/Board Member 78 2016-01-31
Date Insider Type Main position Quantity % Market Cap.
7/10/26 Free

Chief Financial Officer

43,399 0.1273%
7/10/26 Free

Chief Operating Officer

29,511 0.0866%
7/10/26 Free

Founder

162,653 0.4771%
Change 5-day change 1-year change 3-year change Capi.($)
-4.13%+4.64%-30.89%-20.12% 2.7B
-0.28%+0.15%+20.09%+4.46% 214B
-0.30%+1.65%-4.08%-23.28% 138B
-0.35%+5.96%-29.71%+8.45% 125B
-0.48%+5.13%-57.09%-11.64% 68.43B
+1.04%+3.34%+6.73%+5.54% 49.38B
-0.91%+9.32%-24.83%-29.57% 47.55B
-1.11%-0.66%+17.59%+14.00% 39.63B
+0.46%-0.30%+27.49%+38.04% 37.26B
-3.23%+12.32%-2.81%-10.73% 32.71B
Average -0.91%+7.36%-7.75%-2.49% 75.48B
Weighted average by Cap. -0.41%+7.54%-4.21%-2.08%

Financials

2026 *2027 *
Net sales 733M 637M 591M 545M 1.03B 70B 1.05B 7B 2.74B 34.76B 2.75B 2.69B 117B 867M 753M 699M 645M 1.21B 82.78B 1.24B 8.28B 3.24B 41.11B 3.26B 3.18B 138B
Net income 66.45M 57.72M 53.6M 49.43M 93.11M 6.34B 94.8M 635M 248M 3.15B 250M 244M 10.6B 123M 107M 99.35M 91.63M 173M 11.76B 176M 1.18B 461M 5.84B 463M 452M 19.64B
Net Debt -393K -341K -317K -292K -551K -37.52M -561K -3.75M -1.47M -18.64M -1.48M -1.44M -62.67M -72.57M -63.03M -58.53M -53.98M -102M -6.93B -104M -693M -271M -3.44B -273M -267M -11.57B
Logo TransMedics Group, Inc.
TransMedics Group, Inc. is a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure. The Company specializes in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Its Organ Care System (OCS) is a portable organ perfusion, optimization and monitoring system that utilizes its customized technology to replicate near-physiologic conditions for donor organs outside the human body. It also developed its National OCS Program (NOP), which is a turnkey solution to provide outsourced organ procurement, OCS perfusion management and transplant logistics services, to provide transplant programs in the United States. Its logistics services include aviation transportation and other coordination activities. Its NOP provides trained organ procurement surgeons, clinical specialists and transplant coordinators that provide an end-to-end clinical solution using its OCS technology.
Employees
898
Date Price Change Volume
26-07-30 US$74.45 -4.55% 564,886
26-07-29 US$78.00 +2.24% 1,227,617
26-07-28 US$76.29 +2.71% 768,597
26-07-27 US$74.28 +2.80% 644,245
26-07-24 US$72.26 +1.59% 1,139,205
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
78.00USD
Average target price
109.60USD
Spread / Average Target
+40.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMDX Stock